Travere Therapeutics (TVTX) Share-based Compensation (2013 - 2026)
Travere Therapeutics (TVTX) reported Share-based Compensation of $21.79 million for Q2 2026, up 104.6% from $10.65 million a year earlier and up 34.9% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Share-based Compensation (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Travere Therapeutics' Share-based Compensation came in at $60.66 million, up 54.1% year-over-year; for FY2025, it came in at $44.87 million, up 21.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $36.91 million in FY2024 (-16.6%), $44.25 million in FY2023 (+16.0%), $38.14 million in FY2022 (+29.0%) and $29.57 million in FY2021 (+25.2%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2013.
- Year over year, Share-based Compensation has now increased in each of the last seven quarters, with growth averaging 27.4% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q2 2026 (growth of 104.6%); the low point was Q3 2024 (a decline of 29.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $16.15 million (Q1 2026), $11.46 million (Q4 2025) and $11.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn | 21.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.79 Mn |
| Mar 31, 2026 | 16.15 Mn |
| Dec 31, 2025 | 11.46 Mn |
| Sep 30, 2025 | 11.26 Mn |
| Jun 30, 2025 | 10.65 Mn |
| Mar 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.02 Mn |
| Jun 30, 2024 | 9.92 Mn |
| Mar 31, 2024 | 9.76 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Sep 30, 2023 | 11.32 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 13.47 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 8.19 Mn |
| Dec 31, 2021 | 7.38 Mn |
| Sep 30, 2021 | 6.99 Mn |
API Access
Travere Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();